INTRODUCTION

RESULTS
86
Strategy for formation of kidney organoid tissue for engraftment 87 Directed differentiation of PSCs generates a mix of kidney progenitor cells that is predicted to 88 represent the repertoire of cell types within the mesoderm that gives rise to the nephron, 89
interstitium and vasculature of the fetal kidney. We therefore reasoned that culturing these cells 90
in the organotypic conditions developed for culture of the rodent kidney (Saxen, 1987) would be 91 a logical starting point for the formation of new human kidney tissue from PSCs. After 92 performing the 9 day directed differentiation procedure for WTC11 iPSCs or H9 human 93 embryonic stem cells (ESCs) as described by (Morizane et al., 2015) , we dispersed the cells and 94 aggregated them by resuspending the cells in a low volume to form a dense slurry and pipetting 95 carefully into a droplet on the hydrophobic surface of a polycarbonate filter. At this point culture 96
conditions were switched to those developed for primary nephron progenitor cells (NPCs) 97 (Brown et al., 2015) ; APEL 2 medium supplemented with protein free hybridoma medium, 98 BMP7, FGF9, and heparin. In preparatory experiments, we found that the addition of BMP7, 99 FGF9 and heparin promote the viability of cultured cells generated by directed differentiation 100 (data not shown) and we determined that these factors could be removed from the medium after 101 the first 4 days of aggregate culture to reduce cost (Fig. 1A) . The mix of cells resulting from 102 directed differentiation is predicted to contain either no or only a very small number of 103 progenitors for the collecting duct system (Islam and Nishinakamura, 2019) , which is known to 104 serve as the inducer of nephron epithelium differentiation (Carroll et al., 2005) . In prior 105 experiments we have provided the Wnt stimulus that induces mesenchyme-to-epithelium 106 transition through treatment with the small molecule GSK3 inhibitor CHIR 99021 (Brown et al., 107 2015; Gupta et al., 2019) . However, in a series of titrations aimed at determining the dose of 108 CHIR to use to initiate directed differentiation of WTC11 iPSCs to kidney progenitors, 109 spontaneous epithelial differentiation can be seen at day 9 of the directed differentiation, prior to 110 detachment of cells and organoid formation (Fig. S1 ), and we therefore reasoned that cells may 111 not require CHIR 99021 treatment for epithelial differentiation in aggregate culture. CHIR 99021 112 is a potent inhibitor of GSK3 and is expected to have multiple effects other than activating 113
Wnt/β-catenin signaling. Thus, omitting it from our differentiation protocol for tissue 114 engraftment would be highly beneficial as it would reduce the scope for off-target effects. We 115 found that kidney progenitor cells derived from directed differentiation of PSCs did indeed form 116 epithelia following aggregation without CHIR treatment in our conditions ( Fig. 1B, C) . However, 117 the epithelialization process does not appear efficient as large areas of undifferentiated cells can 118 be seen in aggregates. For engraftment, we reasoned that it is important to convert the vast 119 majority of cells in the aggregate to epithelium in order to avoid out-competition by 120 undifferentiated cell types over the several-week period required for vascularization/perfusion, 121
and we therefore developed the aggregate culture method further to enhance mesenchyme-to-122 epithelium transition. 123
Nephron formation in the kidney occurs in waves and undifferentiated NPCs are located 124 immediately adjacent to epithelializing nephrons. Recent studies of human fetal kidney 125 development suggest that there is gradual contribution of NPCs to the forming nephron, and that 126 the differentiation fate of cells is dependent on when they are recruited into the nascent structure; 127 time-dependent fate acquisition (Lindstrom et al., 2018a) . To establish a culture system in which 128
NPCs could be added to epithelializing nephrons over time, we mixed newly differentiated cells 129 with cells that had been aggregated on polycarbonate filters to allow formation of epithelia. To 130 ascertain at which stages of differentiation it might be possible to improve epithelialization by 131 this heterochronic recombination, we staggered directed differentiation protocols so that we 132 could mix newly differentiated cells with cells that had been aggregated in organotypic 133 conditions for 1, 2, or 3 days ( Fig. S2 ). We found that recombination of newly differentiated 134 kidney progenitor cells with cells that had been aggregated and cultured for 2 days generated 135 organoids with the most tightly packed epithelial structures ( Fig. 2A -C). To quantify this effect, 136
we compared the degree of staining for molecular markers of podocyte (podocalyxin), proximal 137 tubule glycoproteins (lotus lectin), and distal tubule (cadherin 1) between organoids derived from 138 an aggregate of a single population of cells from directed differentiation versus organoids from a 139 heterochronic mix ( Fig. 2D ). Compared with aggregates cultured from only the first batch of 140 directed differentiation cells or from only the second batch of directed differentiation cells, 141
aggregates generated by heterochronic mixing displayed approximately double the number of 142 structures stained for each molecular marker. On close examination, aggregates derived by 143 heterochronic mixing contained proximal tubule cells ( Fig. 2E ), distal tubule cells ( Fig. 2F ), 144
connecting segment or collecting duct ( Fig. 2G ), podocytes ( Fig. 2H ), endothelial cells ( Fig. 2H ), 145
and stromal cells ( Fig. 2I ). Interestingly, the network of CD31-expressing presumptive 146 endothelial cells in organoids from heterochronic mixing is more extensive and complex than 147 that seen in organoids generated from a single directed differentiation population ( Fig. S3 ). 148
In summary, our protocol efficiently generates organoids with tightly packed nephron 149 epithelia and endothelial networks that are suitable for engraftment without the need for 150 stimulation of organoid epithelialization by treatment with CHIR 99021 or other Wnt stimulators 151 that may cause off-target effects. 152 153
Contributions of the two heterochronic cell batches to nephron and interstitial cell types 154
To determine if the two batches of cells used for heterochronic recombination contribute 155 equivalently to the different cell types in the epithelialized aggregate, we performed a series of 156 experiments in which we combined H9 human embryonic stem cells with H9 cells that have 157 been modified to express a fluorescently tagged H2B histone subunit under the control of the 158 ubiquitous CAG enhancer-promoter. Fluorescently tagged H9 cells (H9-FP) were either 159 incorporated as the first batch with unlabeled cells as the second batch ( Fig. 3A ) or as the second 160 batch, with unlabeled batch 1 cells ( Fig. 3B ). H9-FP cells introduced in either batch 1 or batch 2 161 contribute to podocyte ( of NPCs that are depleted early in the process of epithelialization, we quantified cells labeled 170 with the NPC markers SIX2 and WT1 and the marker of early NPC differentiation LHX1. Flow 171 cytometry analysis was performed on both heterochronic batches: newly differentiated cells and 172 cells that had been aggregated for 2 days. Consistent with the original report (Morizane et al., 173 2015) , the newly differentiated cell mix contains approximately 90% SIX2+ cells ( Fig. 3O ). This 174
proportion is reduced to 70% after 2 days of aggregate culture. Conversely, the proportion of 175 LHX1+ cells ( Fig. 3P ) increases from 35% in newly differentiated cells to 86% after 2 days of 176 aggregate culture indicating that the majority of cells have undergone differentiation. In the fetal 177 kidney, some SIX2 expression is maintained in differentiating cells of the early nephron 178 (Lindstrom et al., 2018b) , which may explain why SIX2 expression is maintained at 70% while 179 86% of cells express the differentiation marker LHX1. Interestingly, the independent NPC 180 marker WT1 ( Fig. 3Q ) is expressed in 57% of newly differentiated cells but marks only 26% of 181 cells after 2 days of aggregate culture. In summary, 2 days of aggregate culture result in 182 widespread differentiation of LHX1+ cells and depletion of SIX2+/LHX1-NPCs, supporting the 183 notion that improved differentiation of the heterochronic mix compared to a single batch is due 184
to replenishment of the NPC population. 185 186
Engrafted kidney organoids are vascularized and form both nephron and interstitial cell 187 types 188
To determine if kidney tissue derived from heterochronic recombination forms perfused tissue in 189 vivo, we engrafted organoids under the kidney capsules of severely immunocompromised NSG 190 mice. The scheme for organoid differentiation and engraftment is shown in Figure 4A . Twenty 191 organoids of 1-1.5mm diameter and 0.25-0.5mm thickness were engrafted into a single 192 subcapsular site in each animal, and animals were sacrificed 3 weeks after engraftment. 193
Extensive growth of engrafted tissue was seen ( Fig. 4B-D) , and kidneys were vibratome 194 sectioned for whole mount molecular marker analysis. Staining with the endothelial marker 195 CD31 revealed widespread vascularization of the graft, emanating from the host kidney ( Fig. 4E ).
196
Higher magnification imaging reveals patent vessels connecting with clusters of WT1/Podxl-197 labeled presumptive podocytes ( Fig. 4F ). Glomeruli with characteristic morphology including 198 complex capillary structures and Bowman's space are found throughout the graft (Fig. 4G,H) . 199 Staining for the extracellular matrix proteins collagen I, collagen IV and laminin reveals 200 basement membrane morphology similar to glomeruli in the host ( Figure S4 ); HNF4a and LTL 201 label proximal tubule ( Fig. 4I ,J,K); cadherin1, Tamm Horsfall protein, and BRN1 mark distal 202 tubule segments ( Fig. 4J ,K,L); GATA3, DBA, and KRT8 mark extreme distal tubule segments 203 or collecting duct ( Fig. 4M,N) ; Renin is expressed in subsets of cells at the base of glomeruli 204
indicating differentiation of the juxtaglomerular apparatus ( Fig. 4O ). In summary, marker 205 analysis showed that the cardinal cell types of the kidney are present in the graft, and that the 206 tissue is vascularized. To ascertain which of the cells in grafts derive from human and which 207 derive from mouse, we stained tissue for human nuclear antigen ( Fig. 4P-U) . Counterstain for the 208 cell types listed above revealed that all cell types that differentiate in the subcapsular space 209 derive from the human graft, with the exception of the CD31 and endomucin-expressing 210 endothelium ( Fig. 4T,U ), which appears to be exclusively derived from the host. 211 212
Micro computed tomography reveals perfusion 2 weeks after engraftment 213
Having ascertained that organoids derived from heterochronic recombination of human kidney 214 progenitors from directed differentiation are vascularized and maintained in vivo, we wanted to 215 develop a method with which we could track the perfusion of grafts without having to sacrifice 216 mice. This would enable longitudinal studies of graft retention and open up possibilities to 217 monitor performance of the graft following drug treatment. Attempts to use MRI showed some 218 promise but the long scan times required for imaging together with the high cost deterred us from 219 pursuing this strategy. Instead, we used traditional X-ray technology with an iodinated contrast 220 agent. To enable three dimensional imaging, we developed settings for micro-computed 221 tomography. Animals were imaged 3 times at 1-week intervals following engraftment using the 222 procedure outlined in figure 5A . As expected, only calcified structures and kidneys are radio-223 opaque in animals following administration of contrast agent; note the absence of signal in the 224 adrenal at the pole of the kidney (Fig. 5B ). Although contrast agent circulates through soft 225 tissues surrounding the kidneys, it does not accumulate there and the concentration is insufficient 226
to generate a signal at the settings used. Accumulation of sufficient quantities of iodinated 227 compound in the graft to generate signal would signify that the contrast agent is being cleared 228 through the tissue and would provide both a confirmation that the tissue is perfused, and some 229 measure of function. Interestingly, subcapsular grafts are not radio-opaque after 1 week (Fig. 5B ), 230
indicating that they are either not yet adequately perfused, or that they are not sufficiently 231 functional to accumulate iodinated compound. By 2 weeks after surgery (Fig. 5C ), the graft has 232 become diffusely radio-opaque confirming vascularization. By 3 weeks (Fig. 5D ) the 233 morphology of the contrast image has changed and there are regions of intense accumulation of 234 iodinated compound within the graft, indicating functional compartmentalization within the graft. 235
To confirm connection of the graft vasculature to the systemic circulation, we 236 administered a retro-orbital injection of FITC-labeled Griffonia Simplificata Isolectin B4 (FITC-237 IB4) to host animals immediately prior to sacrifice. FITC-IB4 binds glycoproteins on the luminal 238 surface of endothelial cells, and can thus be used to confirm that systemic blood is circulating 239 through graft vasculature. Whole mount imaging of vibratome sections of engrafted tissue 240 revealed extensive networks of labeled vessels (Fig. 5E ). Interestingly, co-staining with the 241 endothelial markers CD31 and endomucin reveal that the graft is compartmentalized into the 242 highly vascularized and poorly vascularized regions ( Fig. 5F ). Within vascularized regions, 243
FITC-IB4 stained vasculature is intimately associated with WT1/PODXL-labeled clusters of 244 presumptive podocytes ( Fig. 5G ), supporting systemic circulation through glomeruli in the graft. 245
Systemic circulation through glomeruli and evidence of distended Bowman's capsules ( Fig.  246 4G,H,P,Q) indicates that blood is being filtered in the graft tissue. To test whether filtration 247 might be occurring, we administered retroorbital injections of fluorescently labeled dextran to 248 hosts and monitored uptake in the proximal tubules of the graft. Dextran (glucose) in the 249 systemic circulation passes over the glomerular filtration barrier and is actively reclaimed by 250 epithelial cells of the proximal tubule. An example of a proximal tubule from the host kidney is 251 shown in figure 5G ; note the accumulation of FITC-dextran in vesicles. Similarly, HNF4a and 252 LTL labeled proximal tubule epithelial cells within the graft show uptake FITC-dextran ( Fig.  253 5H), although the size of vesicles appears more modest than that seen in the host kidney. Based 254 on these findings, we conclude that there is circulation of systemic blood through the vasculature 255 of the graft, that this blood is filtered, and that the proximal tubule is sufficiently differentiated to 256 actively reclaim glucose. Thus, the engrafted human kidney tissue derived from directed 257 differentiation shows hallmark signs of function, providing an important proof of principle and 258 motivating further development of this technology with the aim of functional testing in disease 259 models. One issue that complicates the use of these grafts for functional testing is the 260 overabundance of stromal cells, which are highly proliferative and in time may out-compete 261 functional graft tissue. 262 263
Proliferation of stroma in grafted organoids from primary cells suggests that 264 environmental factors rather than incomplete iPSC/ESC differentiation are the primary 265 cause of stromal overabundance 266
One important question in understanding the overabundance of stromal cells in grafts of PSC-267 derived kidney tissue is if the subcapsular environment in the adult kidney promotes stromal 268 proliferation in kidney tissue or if this is a problem specific to tissue generated from PSCs. To 269 answer this question, we engrafted E15.5 embryonic kidneys subcapsularly in adult NOD SCID 270 kidneys (Fig. 6A ). Vigorous growth of the embryonic implant could be seen 1 month after 271 engraftment (Fig. 6B) , with abundant vascularized glomeruli (Fig. 6C,D) . Immunostaining with 272 the stromal marker PDGFRβ revealed widespread areas of stromal cells between glomeruli, 273
suggesting that factors associated with subcapsular engraftment promote stromal abundance. To 274 confirm using a primary cell system more closely analogous to PSC-derived organoids, we used 275 the nephrogenic zone cell isolation technique (Blank et al., 2009) to generate organoids 276 composed of primary E17.5 nephrogenic zone cells using a similar aggregation and organotypic 277 culture method as was used for PSC-derived directed differentiation cultures. Organoids derived 278 from NZCs are morphologically very similar to those derived from PSCs (Fig. 6F ). NZC 279 organoids were subcapsularly engrafted in adult NSG mice and harvested after 3 weeks. At this 280 point, extensive glomerulogenesis was noted (Fig. 6G) , and the tissue showed abundant 281 investment of CD31+ endothelial cells (Fig. 6H ). However, staining for PDGFRβ again showed 282
an over-abundance of stromal cells (Fig. 6I) , providing more evidence that the adult subcapsular 283 environment promotes these cells in grafts of primary kidney tissue. 284 285 286 287
DISCUSSION
288
This study shows that heterochronic mixing of cells derived by directed differentiation strongly 289 potentiates the differentiation of kidney tissue in organoids derived from pluripotent stem cells. 290
Nephron progenitor cell contribution to the nascent nephron of the developing kidney is 291 asynchronous (Lindstrom et al., 2018a), and mixing kidney progenitor cells at distinct stages of 292 differentiation is intended to emulate this process. The finding that the two different cell batches 293 in a heterochronic mix contribute differentially to proximal and distal compartments of the 294 nephron supports the idea that heterochronic mixing does indeed promote nephrogenesis by 295 establishing a system for time-dependent differentiation. Further support is based on the 296 observation that the majority of cells derived from directed differentiation undergo conversion to 297 the LHX1-expressing epithelial cell precursor state during the first 2 days after aggregation, and 298
we infer from this that the NPC population is severely depleted. Supplementing with a newly 299 differentiated batch of NPCs at this point replenishes this population, contributing to the 300 proximal nephron regions. 301 302
Engrafted organoids differentiated using the heterochronic mixing strategy are efficiently 303 vascularized and form characteristic nephron components in vivo. These are exclusively derived 304 from the engrafted cells with the exception of the endothelium, which appears exclusively 305 derived from the host. This feature of the engraftment is puzzling, since a well-developed 306 network of endothelial cells is found in the organoid prior to engraftment. Since the complex 307 glomerular vasculature can be derived from the host, this finding does not present a limitation, 308
but rather raises the question why endothelial cells differentiated using our modification of the 309 (Morizane et al., 2015) protocol do not contribute to blood vessels in the graft. Endothelial cells 310 are known to be extremely fastidious in their growth requirements and protocols for 311 differentiation of cells with potential to form functional vasculature in vivo differ significantly 312 from the conditions that we used. Thus, it seems likely that our culture conditions do not provide 313 key signals for differentiation of functional endothelial cells. 314 315
In vivo analysis of engrafted kidney tissue is essential for longitudinal studies, for example drug 316 treatments. However, simple technology to detect and track subcapsular grafts without 317 sacrificing the host animals has not been available. The use of microCT with iodinated contrast 318 provides a rapid and relatively simple method for evaluating whether grafts have become 319 vascularized and if they are functionally concentrating contrast agent. In its current form, weekly 320 scanning provides information on whether grafts have taken, their size and if they are displaying 321 even enrichment of the contrast agent. In large studies comparing organoids generated from 322 different patient iPSCs or iPSC with different genetic mutations, it will be important to interpret 323 end-point analyses in the form of histology and functional measurements such as FITC-dextran 324 incorporation in light of the dynamic changes in the graft over the engraftment period. 325 326
Stromal cells expressing appropriate molecular markers are found between epithelial structures 327 in organoids prior to engraftment. However, this population expands excessively following 328 engraftment. One possible interpretation would be that cells derived from directed differentiation 329
are not stable in their differentiation state, leading to de-differentiation of epithelial cells to 330 stroma. Genetic studies have for example shown that loss of expression of the transcription 331 factor PAX2 causes NPCs to assume a stromal-like identity in the developing kidney (Naiman et 332 al., 2017) . Our finding that wild type embryonic kidneys engrafted under the kidney capsule 333
show similar stromal accumulation suggests that this is not a feature of the directed 334 differentiation process, but instead is associated with the micro-environment. One obvious 335 difference between a subcapsular graft and a developing kidney is of course the collecting duct 336 system. To date we have not observed any tubular connections between the graft and the host 337 and based on this we suggest that degenerative changes in the graft are most likely due to the 338 lack of urine outflow. Our future developments of engraftment technology will focus on 339 establishing connections for urine outflow so that we can reach the goal of functional testing in 340 animal disease models. 341 342 343 Directed differentiation and generation of kidney organoids: We differentiated hPSCs to 362 kidney progenitors according to (Morizane et al., 2015) . In brief, WTC11 were plated at a 363 density of 1.4×10 4 cells/cm 2 in a six well plate. On day three, once cells became approximately 364 50% confluent, medium was replaced with Advanced RPMI 1640 (Thermo Fisher Scientific), 1× 365
MATERIALS & METHODS
GlutaMAX ™ (Thermo Fisher Scientific), 10 μM CHIR99021 (Reprocell), and 5 ng/ml Noggin 366 (R&D Systems). On Day 4, medium was replaced with Advanced RPMI 1640 containing 10 367 ng/ml Activin A (R&D) and 1X GlutaMAX ™. On Day 7, medium was replaced with Advanced 368 RPMI 1640 containing 10 ng/ml FGF9 (R&D) and 1X GlutaMAX ™ for the next 2 days. H9 or 369 H9-FP, cells were plated at a density of 1.7×10 4 cells/cm 2 in a six well plate. On day three, once 370 cells became approximately 50% confluent, media was replaced with differentiation medium 371
containing Advanced RPMI 1640, 1× GlutaMAX ™ and 8 μM CHIR99021 (Reprocell). From 372 day 4 to day 9, the same protocol was followed as for WTC11. On Day 9 of directed 373 differentiation, differentiated cells were designated "kidney progenitor cells". Kidney progenitor 374 cells were harvested with TrypLE Express (Thermo Fisher Scientific) and resuspended at a 375 density of 2.5×10 5 cells/µl in organoid initiation medium containing APEL2 (Stemcell 376
Technologies), 1.5% PFHM-II (Thermo Fisher Scientific), 100 ng/ml FGF9, 100 ng/ml BMP7 377 (R&D Systems) and 1 μg/ml Heparin (Sigma-Aldrich). 1 ml/well of this medium was added to 378 wells in a 24 well plate and Isopore Membranes (EMD Millipore) were suspended at the surface 379 of the medium to create an air-liquid interface. Resuspended cells were spotted on top of the 380 filter (2 μl/aggregate). Medium was changed every 48 hours or when it turned yellow. All growth 381 factors were removed from the medium 4 days after aggregation and organoids were cultured for 382 a further 5 days with APEL2 containing 1.5% PFHM-II. 383
Organoid generation through heterochronic recombination: For heterochronic 384 recombination of hPSCs, directed differentiation was performed on two batches of cells 385 staggered two days apart. On day 9, the first batch of kidney progenitor cells was aggregated at 386
the air-liquid interface as described above. 2 days later, aggregated cells were gently broken into 387 small cell clusters with a 200µl micropipette and mixed with newly differentiated kidney 388 progenitor cells. 1 dissociated aggregate was mixed with 5×10 5 kidney progenitor cells in 4µl of 389 organoid initiation medium and re-aggregated in 2 aggregates at the air-liquid interface. Medium 390 was changed every 48 hours or when it turned yellow. All growth factors were removed from the 391 medium 4 days after aggregation and organoids were cultured for a further 5 days with APEL2 392 containing 1.5% PFHM-II. 393
NZCs Organoid generation and engraftment: NZCs were derived from E17.5 mouse kidneys 394 according to (Blank et al., 2009 ) and suspended at a cell density 2.5×10 5 cells per µl medium 395 containing APEL2, 1.5% PFHM-II, 200 ng/ml of FGF9 and 1 μg/ml of Heparin. In a 24 well 396 plate, 1 ml/well of medium was added per well and Isopore Membranes were suspended at the 397 surface of the medium to create an air-liquid interface. NZCs were aggregated on top of the filter 398 by spotting 2 µl per aggregate. Medium was changed every 48 hours or when it became yellow. 399 5 days after aggregation, all growth factors were removed and organoids were cultured with 400 APEL2 containing 1.5% PFHM-II throughout for a further 4 days and then engrafted under the 401 kidney capsule of adult mice. Mice were sacrificed 3 weeks after engraftment. 402
Embryonic mouse kidneys for engraftment: Pregnant dams were sacrificed at E15.5 and 403 kidneys were dissected out of the embryos. Kidneys were then engrafted under the kidney 404 capsules of adult NOD SCID mice (Charles River Laboratories). Graft recipients were sacrificed 405 one month or two months after the engraftment and the kidneys were sectioned for H&E staining 406 and immunostaining. 407
Flow cytometry: Kidney progenitor cells were characterized by flow cytometry at the end of 408 day 9 of the directed differentiation protocol and 2 days after aggregation at the air-liquid 409
interface. Cells were incubated with TrypLE Express for 5 min at 37 0 C to generate single cell 410 suspensions and strained through a 40 µm mesh (BD Biosciences For quantification, integrated density of fluorescent images was measured using Image J. For 448 each antibody stain, three separate fields from three different specimens were measured, and the 449 mean was plotted with standard error bars. Kidneys with engrafted organoids were pared down 450 so that only a transverse slab of host kidney underlying the graft remained and this tissue was 451 fixed with 4% paraformaldehyde/PBS for 1 hour per mm thickness of the slab at 4°C before 452 vibratome sectioning at 100µm. Immunostaining was performed using the same method as for 453
organoids. For analysis of the embryonic kidney engraftment, kidneys were fixed overnight in 454 4% paraformaldehyde/PBS at 4 °C, paraffin embedded and sectioned. Sections were subjected 455 to heat-induced epitope retrieval with Tris-EDTA, blocked in PBS with 0.1% Triton X-100 and 456 5% FBS and incubated overnight with primary antibodies. Secondary antibodies were added for 457 1h at room temperature. Slides then were mounted with Vectashield and photographed by 458 scanning laser confocal microscopy (Zeiss LSM-700). The primary antibodies used are shown in 459 Table 1 . 460 461 462 463 Proximal tubule (LTL) and distal tubule (Cdh1). 534 535
